Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Forxiga receives positive EU CHMP opinion for the treatment of adults with type-1 diabetes
-
Linzess (linaclotide) approved in China for the treatment of irritable bowel syndrome with constipation
-
AstraZeneca announces organisational changes
-
Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia
-
Bevespi Aerosphere approved in the EU for chronic obstructive pulmonary disease
-
Lynparza meets primary endpoint in Phase III SOLO-3 trial for the treatment of relapsed BRCA-mutated advanced ovarian cancer
-
Lynparza approved by US FDA for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis
-
AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
-
Update on the Phase III EAGLE trial of Imfinzi and tremelimumab in advanced head and neck cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
